PUBLIC CONTRACT · 2021
4180573/2020-aq. Central A5350 - Adalimumab 40 mg (100 mg/ml caneta 0.4 ml) sol inj
- Contract value
- €19,200.00
- Signed on
- 11 February 2021
- Procedure
- Ao abrigo de acordo-quadro (art.º 258.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 7477641PUBLISHED SUBJECT
4180573/2020-AQ. CENTRAL A5350 - ADALIMUMAB 40 MG (100 MG/ML CANETA 0.4 ML) SOL INJ
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Setúbal, Barreiro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- AbbVie, LDA · Tax ID 510229050
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €19,200.00
- Procedure base price
- €19,200.00
- Total effective price
- €19,200.00
- Publication date
- 18 February 2021
- Award date
- 11 February 2021
- Signing date
- 11 February 2021
- Performance period
- 5 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 258.º)
- Award criterion
- Preço ou custo
- CPV code
- 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2018/64 - Medicamentos Diversos
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5128596
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.